Macugen OverviewPegaptanib sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD). It was discovered by NeXstar Pharmaceuticals and licensed in 2000 to EyeTech Pharmaceuticals, now OSI Pharmaceuticals, for late stage development and marketing in the United States. Outside the US pegaptanib is marketed by Pfizer. Approval was granted by the U.S. Food and Drug Administration (FDA) i...
Read more Macugen Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegaptanib
Recent Macugen Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 0.3mg/0.09ml, eq 0.3mg acid/0.09ml
NDC Database Records for Macugen: (1 result)Sorted by National Drug Code
- 68782-001 Macugen 3.47 mg/ml Intravitreal Injection, Solution by Eyetech Inc.
Other drugs which contain Pegaptanib or a similar ingredient: (1 result)
Related Macugen Topics: